Need professional-grade analysis? Visit stockanalysis.com
$3.90B
87.76
N/A
N/A
Price Chart
Risk-Adjusted Performance
Sotera Health Co (SHC) Price Performance
Sotera Health Co (SHC) trades on United States in USD. The company is classified in the Healthcare sector under the Health Care Plans industry. The stock currently trades at $15.97, down 2.02% from the previous close.
Over the past year, SHC has traded between a low of $10.87 and a high of $19.35. The stock has gained 46.9% over this period. It is currently 17.5% below its 52-week high.
Sotera Health Co has a market capitalization of $3.90B, with a price-to-earnings ratio of 87.76.
About Sotera Health Co
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.
Compare Sotera Health Co
Side-by-side comparison against top Healthcare peers.
Company Info
- Sector
- Healthcare
- Industry
- Health Care Plans
- Exchange
- United States
- Currency
- USD
- Country
- United States
Financial Metrics
- Revenue (TTM)
- $1.05B
- EBITDA
- $553.36M
- Profit Margin
- 6.70%
- EPS (TTM)
- 0.27
- Book Value
- 2.13
Technical Indicators
- 52 Week High
- $19.85
- 52 Week Low
- $10.68
- 50 Day MA
- $16.13
- 200 Day MA
- $15.62
- Beta
- 1.88
Valuation
- Trailing P/E
- 50.74
- Forward P/E
- 13.09
- Price/Sales
- 3.35
- Price/Book
- 6.43
- Enterprise Value
- $6.29B